
Being Cure Pharma Private Limited
About Being Cure Pharma Private Limited
Data last updated:
Being Cure Pharma Private Limited is a private limited company based in Panvel, Maharashtra, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 02 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2017PTC322832.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Meraj Ahmad and Mohammad Belal Khan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 201 C Wing 2nd Flower Nikki Tower Israil Talav Pnavel, Panvel, Maharashtra, India – 410206.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.88 Lakh, a growth of 77% compared to the previous year. For the same year it recorded a net loss of ₹1,810 (net margin -0.1%) and EBITDA of -₹1,810 (EBITDA margin -0.1%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 25% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Being Cure Pharma has one previous CIN (Corporate Identification Number): U24304UP2017PTC093777. The current CIN is U24304MH2017PTC322832, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24304MH2017PTC322832 | Current |
| U24304UP2017PTC093777 | Previous |
Contact details
Being Cure Pharma Private Limited's registered office is in Panvel, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address201 C Wing 2nd Flower Nikki Tower Israil Talav Pnavel, Panvel, Maharashtra, India – 410206
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Being Cure Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Being Cure Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Being Cure Pharma Private Limited, buy the company report.
Financials of Being Cure Pharma Private Limited
FY 2025 filings availableBeing Cure Pharma Private Limited reported revenue of ₹12.88 Lakh (up 77% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 77% growth in the latest year. EBITDA fell 429% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1,810 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,810 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.1% | ||||
| Net Profit Margin | -0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Being Cure Pharma Private Limited, buy the company report.
Board of directors of Being Cure Pharma Private Limited
Being Cure Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meraj Ahmad Also directs: Muza Pharma Private Limited | Director | 02 Jun 2017 | 9 Years 5 Months | Current |
| Mohammad Belal Khan | Director | 02 Jun 2017 | 9 Years 5 Months | Current |
Peer comparison
Being Cure Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mittitech Home Decor Private Limited | ₹12.91 Lakh (FY 2024) | 129051800.0% | Nadia, West Bengal, India | |||
| Nutribasket Wellness Nutrition Private Limited | ₹12.9 Lakh (FY 2025) | -55.0% | Bhopal, Madhya Pradesh, India | |||
| RSR Logic Private Limited | ₹12.9 Lakh (FY 2017) | 16.0% | Delhi, India | |||
| Kass Mart & Retail Private Limited | ₹12.89 Lakh (FY 2024) | -48.0% | Noida, Uttar Pradesh, India | |||
| Florination Trading India Private Limited | ₹12.89 Lakh (FY 2016) | New Delhi, Delhi, India | ||||
| Being Cure Pharma Private Limitedthis company | ₹12.88 Lakh (FY 2025) | -₹1,810 | -0.1% | 77.0% | Panvel, Maharashtra, India | |
| Navneet Hallmarking and Refinery Private Limited | ₹12.88 Lakh (FY 2025) | -52.0% | Hyderabad, Telangana, India | |||
| Lucas Life Sciences Private Limited | ₹12.88 Lakh (FY 2025) | 32.0% | New Delhi, Delhi, India | |||
| TNG Developers Private Limted | ₹12.88 Lakh (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Brij Behari Realty Private Limited | ₹12.88 Lakh (FY 2025) | -55.0% | North 24 Parganas, West Bengal, India | |||
| BMVS India Private Limited | ₹12.88 Lakh (FY 2025) | -43.0% | Bengaluru, Karnataka, India |
To see the full peer comparison of Being Cure Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Being Cure Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Being Cure Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Being Cure Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Being Cure Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Meraj Ahmad was appointed as Director on 02 Jun 2017.
Frequently asked questions
Being Cure Pharma is an active private limited company based in Panvel, Maharashtra, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 02 June 2017 (9+ years old) and is registered under CIN U24304MH2017PTC322832.
Being Cure Pharma has 2 current directors:
- Meraj Ahmad - Director
- Mohammad Belal Khan - Director
The latest financial statements of Being Cure Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Being Cure Pharma is U24304MH2017PTC322832. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Being Cure Pharma was incorporated on 02 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Being Cure Pharma by revenue are Mittitech Home Decor Private Limited, Nutribasket Wellness Nutrition Private Limited, RSR Logic Private Limited, Kass Mart & Retail Private Limited, Florination Trading India Private Limited and 5 more, all in the same principal business activity (retail trading).
Meraj Ahmad was appointed as Director on 02 Jun 2017. Mohammad Belal Khan was appointed as Director on 02 Jun 2017.
The registered office of Being Cure Pharma is at 201 C Wing 2nd Flower Nikki Tower Israil Talav Pnavel, Panvel, Maharashtra, India – 410206.
Being Cure Pharma operates in the food and beverages industry, in the manufacturing segment.
The compliance status of Being Cure Pharma is compliant as of 06 August 2026. The company is actively filing with the Registrar of Companies.
Being Cure Pharma can be reached at its registered office: 201 C Wing 2nd Flower Nikki Tower Israil Talav Pnavel, Panvel, Maharashtra, India – 410206.

